Quantum Leap Healthcare Collaborative
The I-SPY Trials
For Patients
ABOUT
I-SPY 2 Trial
Resources
Funding & Support
Agents & Results
I-SPY Agents
Manuscripts
Meeting Abstracts
Collaborate
Proposal Submissions
Partner With Us
News
Latest News
Feature Articles
I-SPY in the News
Media Center
People
Leadership
Clinical Sites
Contact Us
FOR PATIENTS
News
I-SPY in the News
Widely hailed as the future of phase II drug development, the adaptive I-SPY2 platform trial has set a new benchmark for efficiency, through innovation in trial design and clinical operations.
Close
Close
Close
I-SPY Email List Sign-up
First Name:
Last Name:
Email Address:
Breast cancer patient/family/friend
Research/Medical Professional
Just Interested
Thank you, your subscription is activated.
If you change your mind, you can
unsubscribe
at any time.
Oops! Something went wrong while submitting the form.
Highlights
I-SPY updates breast cancer subtypes with response-predictive biomarkers generated across 10 therapies
Cancer Cell
June 14, 2022
Esserman brings urgency for ‘learning healthcare’ to learn faster, better
BioCentury
June 6, 2022
Natera to Present Data from the BEATRICE and I-SPY2 Trials in Early-Stage TNBC and HR+/HER2- Breast Cancer at the 2022 AACR Annual Meeting
Natera, Inc.
April 11, 2022
Recent Coverage
December 14, 2017
-
HemOnc today
Pathologic complete response may be strong surrogate endpoint for breast cancer survival
December 12, 2017
-
BusinessWire
Key Studies Presented at SABCS Demonstrate the Important Role of MammaPrint® for Patient Pre-Selection, Cost-Effectiveness and For Younger Patients
November 29, 2017
-
Targeted Oncology
New Treatment Options Emerging for Patients With HER2+ Breast Cancer
February 23, 2017
-
R&D Magazine
Three Skills Developers Will Need to Thrive in the New Era of Genomic Medicine
January 5, 2017
-
Huffington Post
Top Ten Medical Research Issues and Trends to Watch in 2017
October 26, 2016
-
Cancer Therapy Advisor
Adaptive randomization and the I-SPY 2 trial platform
October 26, 2016
-
Clin Adv Hem Onc
The I-SPY approach to drug development: An interview with Laura Esserman
September 5, 2016
-
BioCentury
Back to School: Haste, not waste
July 7, 2016
-
NEJM
I-SPY 2 - A glimpse of future phase 2 drug development?
June 25, 2016
-
Oncology Times
I-SPY 2 shows efficacy of T-DM1-Pertuzumab
November 2, 2015
-
Managed Care Mag.
Can Platform Trials Speed Cancer Drug Development?
September 28, 2015
-
NY Times
A breast cancer surgeon who keeps challenging the status quo
Previous
Next
Don't miss a thing! Get I-SPY results, news and event information delivered right to your inbox.
Sign Up
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.